N. Manuel

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Terry L. Smith, D. Berry, G. Hortobagyi, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

G. Hortobagyi, S. Singletary, F. Ames, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective E valuation o f P aclitaxel V ersus C ombination Chemotherapy W ith F luorouracil, D oxorubicin, and C yclophosphamide a s N eoadjuvant T herapy i n P atients With O perable B reast C ancer

G. Hortobagyi, S. Singletary, F. Ames, 1999 .